The combined results from normal human tissues, cancer cell lines and breast cancer specimens suggest that alteration of CEACAM1 splicing could be a common feature of breast cancer and an optimal ratio between the short and the long cytoplasmic domain splice variants might be required for normal tissue function. The gene discussed is CEACAM1; the disease is breast cancer.